Tag Archives: Nature Medicine
p75 neurotrophin receptor modulation in mild to moderate Alzheimer’s disease
- Posted on May 17, 2024
The 26-week Phase 2a trial met its primary endpoint for safety and tolerability, with biomarker and imaging signals supporting further study.... Read More